These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 15358993)
1. Vigabatrin and tiagabine might have antipanic properties. Zwanzger P; Rupprecht R J Psychopharmacol; 2004 Sep; 18(3):440. PubMed ID: 15358993 [No Abstract] [Full Text] [Related]
2. Anticonvulsants as anxiolytics, part 1: tiagabine and other anticonvulsants with actions on GABA. Stahl SM J Clin Psychiatry; 2004 Mar; 65(3):291-2. PubMed ID: 15096065 [No Abstract] [Full Text] [Related]
3. Questionable tolerability of tiagabine in generalized anxiety disorder. Spielmans GI J Clin Psychopharmacol; 2009 Jun; 29(3):314. PubMed ID: 19440099 [No Abstract] [Full Text] [Related]
5. Pre-clinical studies with the GABAergic compounds vigabatrin and tiagabine. Sills GJ Epileptic Disord; 2003 Mar; 5(1):51-6. PubMed ID: 12773297 [TBL] [Abstract][Full Text] [Related]
6. The use of tiagabine augmentation for treatment-resistant anxiety disorders: a case series. Schwartz TL Psychopharmacol Bull; 2002; 36(2):53-7. PubMed ID: 12397840 [TBL] [Abstract][Full Text] [Related]
7. Vigabatrin and tiagabine are pharmacologically different drugs. A pre-clinical study. Sills GJ; Butler E; Thompson GG; Brodie MJ Seizure; 1999 Oct; 8(7):404-11. PubMed ID: 10600581 [TBL] [Abstract][Full Text] [Related]
9. Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate. Angehagen M; Ben-Menachem E; Rönnbäck L; Hansson E Neurochem Res; 2003 Feb; 28(2):333-40. PubMed ID: 12608706 [TBL] [Abstract][Full Text] [Related]
10. Different effects of GABAergic anticonvulsants on 4-aminopyridine-induced spontaneous GABAergic hyperpolarizations of hippocampal pyramidal cells--implication for their potency in migraine therapy. Leniger T; Wiemann M; Bingmann D; Hufnagel A; Bonnet U Cephalalgia; 2000 Jul; 20(6):533-7. PubMed ID: 11075835 [TBL] [Abstract][Full Text] [Related]
11. Antiepileptic action induced by a combination of vigabatrin and tiagabine. Fueta Y; Kunugita N; Schwarz W Neuroscience; 2005; 132(2):335-45. PubMed ID: 15802187 [TBL] [Abstract][Full Text] [Related]
16. Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy. Luszczki JJ; Czuczwar SJ Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):529-38. PubMed ID: 17204358 [TBL] [Abstract][Full Text] [Related]
17. Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice. Thoeringer CK; Erhardt A; Sillaber I; Mueller MB; Ohl F; Holsboer F; Keck ME J Psychopharmacol; 2010 May; 24(5):733-43. PubMed ID: 19346277 [TBL] [Abstract][Full Text] [Related]
18. The 'number needed to treat' with levetiracetam (LEV): comparison with the other new antiepileptic drugs (AEDs). van Rijckevorsel K; Boon PA Seizure; 2002 Apr; 11 Suppl A():235-6. PubMed ID: 12185762 [No Abstract] [Full Text] [Related]
20. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy. Adkins JC; Noble S Drugs; 1998 Mar; 55(3):437-60. PubMed ID: 9530548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]